131I-Tositumomab (Bexxar®)vs.90Y-Ibritumomab (Zevalin®) Therapy of Low-Grade Refractory/Relapsed Non-Hodgkin Lymphoma

✍ Scribed by Andrei Iagaru; Erik S. Mittra; Kristen Ganjoo; Susan J. Knox; Michael L. Goris

• Book ID: 106571472
• Publisher: Springer-Verlag
• Year: 2009
• Tongue: English
• Weight: 200 KB
• Volume: 12
• Category: Article
• ISSN: 1536-1632
• DOI: 10.1007/s11307-009-0245-9